BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld
Home
» Other news to note for Sept. 29, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Sept. 29, 2020
Sep. 29, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acasti, Aclipse, Advaxis, Annovis, Arbor, Aspargo, Baselaunch, Better Plant, CASI, Celyad, Creative Medical, Cristal, Enesi, EV, Farmalider, Field Trip Psychedelics, Fosun, Global Cancer Technology, J&J, Juventas, Koligo, Lexaria, Lifesci Acquisition, Luca, M8, Merck, Moleculin, Navrogen, Neuropore, Orgenesis, Polyphor, Psygen, Sema4, Soricimed, Sorrento, South Rampart, Tonix, Vincera, Vor.
BioWorld
Briefs
Other news to note
Coronavirus